201 related articles for article (PubMed ID: 22612514)
1. Autopsy case of primary myelofibrosis in which myeloid sarcoma was the initial manifestation of tumor progression.
Morita K; Nakamine H; Inoue R; Takano M; Takeda M; Enomoto Y; Kasai T; Nonomura A; Tanaka H; Amano I; Morii T; Kimura H
Pathol Int; 2012 Jun; 62(6):433-7. PubMed ID: 22612514
[TBL] [Abstract][Full Text] [Related]
2. A case of myeloid sarcoma with correlation to JAK2V617F mutation, complicated by myelofibrosis and secondary acute myeloid leukemia.
Yoshiki Y; Asai T; Ichikawa M; Hangaishi A; Ota S; Imai Y; Takahashi T; Kurokawa M
Intern Med; 2011; 50(21):2649-52. PubMed ID: 22041374
[TBL] [Abstract][Full Text] [Related]
3. Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor.
Novello M; Coli A; Della Pepa GM; Martini M; Doglietto F; De Stefano V; Bellesi S; Pescarmona E; Lauriola L
Neuropathology; 2014 Apr; 34(2):179-84. PubMed ID: 24118374
[TBL] [Abstract][Full Text] [Related]
4. Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management.
Tefferi A
Am J Hematol; 2013 Feb; 88(2):141-50. PubMed ID: 23349007
[TBL] [Abstract][Full Text] [Related]
5. [Isolated myeloid sarcoma involving the mediastinum].
Jelić-Puskarić B; Kardum-Skelin I; Sustercić D; Pazur M; Vrhovac R; Radić-Kristo D; Gredelj-Simec N; Kovacević DO; Plasćak J; Gasparov S; Jaksić B
Acta Med Croatica; 2011 Sep; 65 Suppl 1():133-8. PubMed ID: 23126041
[TBL] [Abstract][Full Text] [Related]
6. JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis.
Hussein K; Bock O; Theophile K; von Neuhoff N; Buhr T; Schlué J; Büsche G; Kreipe H
Exp Hematol; 2009 Oct; 37(10):1186-1193.e7. PubMed ID: 19616600
[TBL] [Abstract][Full Text] [Related]
7. Wild-type JAK2 secondary acute erythroleukemia developing after JAK2-V617F-mutated primary myelofibrosis.
Kreft A; Springer E; Lipka DB; Kirkpatrick CJ
Acta Haematol; 2009; 122(1):36-8. PubMed ID: 19713696
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous myelofibrosis with JAK2 V617F mutation: metastasis, not merely extramedullary hematopoiesis!
Fraga GR; Caughron SK
Am J Dermatopathol; 2010 Oct; 32(7):727-30. PubMed ID: 20859081
[TBL] [Abstract][Full Text] [Related]
9. JAK2-positive Philadelphia-negative myeloproliferative neoplasms.
Sharma A; Buxi G; Marwah S; Yadav R
Indian J Pathol Microbiol; 2011; 54(1):117-20. PubMed ID: 21393891
[TBL] [Abstract][Full Text] [Related]
10. Postsplenectomy sclerosing extramedullary hematopoietic tumor with unexpected good clinical evolution: morphologic, immunohistochemical, and molecular analysis of one case and review of the literature.
Gualco G; Ojopi EB; Chioato L; Cordeiro DL; Negretti F; Bacchi CE
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):291-5. PubMed ID: 20042850
[TBL] [Abstract][Full Text] [Related]
11. MPLW515L mutation in acute megakaryoblastic leukaemia.
Hussein K; Bock O; Theophile K; Schulz-Bischof K; Porwit A; Schlue J; Jonigk D; Kreipe H
Leukemia; 2009 May; 23(5):852-5. PubMed ID: 19194467
[TBL] [Abstract][Full Text] [Related]
12. Myeloid sarcoma involving the breast.
Jelić-Puskarić B; Ostojić-Kolonić S; Planinc-Peraica A; Obad-Kovacević D; Kardum-Skelin I; Jaksić B
Coll Antropol; 2010 Jun; 34(2):641-4. PubMed ID: 20698144
[TBL] [Abstract][Full Text] [Related]
13. Extramedullary peritoneal hematopoiesis combined with tuberculosis in a patient with primary myelofibrosis.
Kim SJ; Lee Y; Kim SH; Kim H; Park KU; Bang SM; Lee JS
Med Oncol; 2009; 26(2):238-41. PubMed ID: 18850308
[TBL] [Abstract][Full Text] [Related]
14. Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management.
Tefferi A
Am J Hematol; 2011 Dec; 86(12):1017-26. PubMed ID: 22086865
[TBL] [Abstract][Full Text] [Related]
15. [Blastic crisis of primary myelofibrosis associated with multiple myeloblastomas ].
Fukushima T; Uchida M; Iwasaki H; Kamiya K; Tanaka T; Yoshimura T; Sasaki K; Tsutani H; Wano Y; Takayama H
Rinsho Ketsueki; 1990 Jan; 31(1):95-9. PubMed ID: 2313911
[TBL] [Abstract][Full Text] [Related]
16. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
17. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
18. Long-term remission with imatinib mesylate in Philadelphia chromosome-positive AML presenting as primary extramedullary myeloid sarcoma.
Ahmed MS; Kroft SH; Davis NB; King DM; Cheng YC
Leuk Res; 2008 Sep; 32(9):1476-9. PubMed ID: 18308388
[TBL] [Abstract][Full Text] [Related]
19. [A case of myelofibrosis that developed polycythemia vera following treatment with ranimustine and then acute myelogenous leukemia (M0)].
Harashima S; Okamura T; Umeno M; Takaki K
Rinsho Ketsueki; 1996 Aug; 37(8):713-8. PubMed ID: 8827883
[TBL] [Abstract][Full Text] [Related]
20. Granulocytic sarcoma in the absence of acute myeloid leukemia: a case report.
Khalid S; Adil SN; Vaziri IA
Indian J Pathol Microbiol; 2007 Jan; 50(1):88-90. PubMed ID: 17474271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
